Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study

BACKGROUND: A safe, simple, effective, and pan-genotypic regimen to treat hepatitis C virus (HCV) infection in patients coinfected with human immunodeficiency virus type 1 (HIV-1) remains a medical need. We assessed the efficacy and safety of the NS5B polymerase inhibitor sofosbuvir and the NS5A inh...

詳細記述

保存先:
書誌詳細
出版年:Clin Infect Dis
主要な著者: Wyles, David, Bräu, Norbert, Kottilil, Shyam, Daar, Eric S, Ruane, Peter, Workowski, Kimberly, Luetkemeyer, Anne, Adeyemi, Oluwatoyin, Kim, Arthur Y, Doehle, Brian, Huang, K C, Mogalian, Erik, Osinusi, Anu, McNally, John, Brainard, Diana M, McHutchison, John G, Naggie, Susanna, Sulkowski, Mark
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2017
主題:
Articles and Commentaries
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6248627/
https://ncbi.nlm.nih.gov/pubmed/28369210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cix260
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料